Member News
Bringing Research Closer to Home
Clinical trials are crucial for making sure that new drugs, treatments, and medical devices are safe and effective. But people living in rural and remote areas, such as northern BC,… Read More
Member News
ISCT Announces Dr. Phil Vanek as next Chief Commercialization Officer
The International Society for Cell & Gene Therapy (ISCT) is delighted to announce the appointment of Phil Vanek, PhD, as the new ISCT Chief Commercialization Officer (CCO), effective January 1, 2025,… Read More
Member News
Acuitas’ CSO Co-Authors Article in Molecular Therapy With Scientists From Children’s Hospital of Philadelphia and Perelman School of Medicine
VANCOUVER, BC – Acuitas’ Chief Scientific Officer, Dr. Ying Tam, collaborated with scientists from the Children’s Hospital of Philadelphia and Perelman School of Medicine to determine whether messenger RNA lipid… Read More
Member News
Vertex Announces FDA Approval of JOURNAVX™ (suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain
JOURNAVX is the first and only approved non-opioid oral pain signal inhibitor and the first new class of pain medicine approved in more than 20 years JOURNAVX is an effective… Read More
Member News
Rakovina Therapeutics Announces Listing on Frankfurt Stock Exchange
VANCOUVER, BC – Rakovina Therapeutics Inc. (TSX-V: RKV), a biopharmaceutical company dedicated to advancing new cancer therapies based on novel DNA-damage response technologies, is pleased to announce that its common… Read More